InvestorsHub Logo
Followers 54
Posts 3420
Boards Moderated 0
Alias Born 10/26/2013

Re: BarrellofHay post# 3130

Thursday, 09/22/2022 6:53:32 AM

Thursday, September 22, 2022 6:53:32 AM

Post# of 3283
Not sure I’m completely following you but if they are pointing out

They state that the chemotherapy/checkpoint "subgroup" of 59 patients had an ORR of 25% and that the ORR of the entire Cohort study was ~28%

Shouldn’t they note that the “subgroup” of 31 patients who didn’t have Chemo/CI would have an ORR of greater than 30%. IMO, pozi should get AA. It seems like they have different standards for more influential Big Pharma than they do for the little guys..